Alembic Pharmaceuticals Ltd — Quarterly Results & Earnings

₹663.25

-2.97%

Profit Growth YoY28.80%Latest quarter

Sales Growth YoY15.91%Latest quarter

Sales CAGR 5Y7.69%5 year compound

Profit CAGR 5Y-7.96%5 year compound

📋

Quarterly Performance

YoY Profit Growth+28.80%

🔥 Exceptional growth

YoY Sales Growth+15.91%

✅ Strong growth

OPM 5Y Average

Operating profit margin

17.01%

EPS Growth 5Y

-8.73%

Interest Coverage

Higher = safer debt servicing

9.29

ROE

11.38%

ROCE

13.05%

💡

Growth Analysis

Alembic Pharmaceuticals Ltd reported YoY profit growth of 28.80% and revenue growth of 15.91% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 7.69% and profits at -7.96% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Alembic Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.